By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Design Corporation 

1102 Columbia Street
Suite 104
Seattle  Washington  98104  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Immune Design Corporation (IMDZ) Updates Positive Data From Lead Cancer Immunotherapy Programs At ASCO Annual Meeting 6/5/2017 10:13:35 AM
New Clinical And Biomarker Data Validate Immune Design Corporation (IMDZ)’s Lead Programs And Discovery Platforms 5/18/2017 8:50:42 AM
Immune Design Corporation (IMDZ) Reports First Quarter 2017 Financial Results and Provides Corporate Update 5/18/2017 8:47:18 AM
Immune Design Corporation (IMDZ) To Report First Quarter 2017 Financial Results & Provide Corporate Update 5/8/2017 8:48:59 AM
Immune Design Corporation (IMDZ) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/8/2017 8:15:11 AM
Immune Design Corporation (IMDZ) To Report Fourth Quarter And Year End 2016 Financial Results And Provide Corporate Update 3/2/2017 8:02:54 AM
Immune Design Corporation (IMDZ) Receives Orphan Drug Designation For G100 Intratumoral Product Candidate 2/22/2017 8:36:37 AM
Immune Design Corporation (IMDZ) Provides Update From Two Discovery Platforms: DC-Tropic Zvex Delivering Multiple Tumor Antigens (Conserved And Neo-Antigens) And G100 For Intratumoral Immunotherapy 12/5/2016 7:52:51 AM
New Immune Design Corporation (IMDZ) Data Highlights Expanded Product Potential Of Zvex® Platform At The 2016 SITC Annual Meeting 11/11/2016 7:58:10 AM
Immune Design Corporation (IMDZ) Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/10/2016 8:18:55 AM
12345678910
//-->